Zepbound® (tirzepatide) — 10 mg
- Medicare
- Priced November 22, 2026
Your cheapest verified route right now
verified price- Per year at 12 fills
- $600
Every route we can price
Verified prices outrank cheaper estimates. Reference rows inform, never win.
- Rank 1
Medicare GLP-1 Bridge
until Dec 31, 2027$50/mo- Zepbound KwikPen ONLY — single-dose vials and single-dose pens are NOT covered
- Pen needles are not covered — buy them separately
- Runs OUTSIDE the Part D plan (central processor: Humana, BIN 028918 / PCN MEDDGLP1BR). Not available if your Part D plan already covers a GLP-1 for you, or if you have T2D, moderate-to-severe OSA, or noncirrhotic MASH (those route through standard Part D). Filling any GLP-1 through your Part D plan after you are approved ends your Bridge eligibility for good — the next Bridge refill is rejected at the counter — and so does moving to a Part D plan type the Bridge does not cover. Which types those are: the Bridge reaches a standalone drug plan (PDP), a Medicare Advantage coordinated care plan with drug coverage (HMO, HMOPOS, and Local and Regional PPO), a Special Needs Plan, an employer or union group waiver plan, and LI NET. It does NOT reach a private fee-for-service plan, a section 1876 cost contract, a section 1833 health care prepayment plan, PACE, a fallback plan or a religious fraternal benefit plan — in one of those you are ineligible however well you meet the clinical criteria, unless you are also enrolled in a standalone PDP. A prescriber must attest on the prior authorization that you met a BMI category: BMI >= 35; or >= 30 with heart failure with preserved ejection fraction, uncontrolled hypertension, or chronic kidney disease stage 3a or above; or >= 27 with pre-diabetes, prior myocardial infarction, prior stroke, or symptomatic peripheral artery disease. That BMI is the one you had when you STARTED GLP-1 therapy, not the one you have now — losing weight since does not disqualify you. The copay does not count toward the Part D deductible or your out-of-pocket maximum, and no coupons apply. There is no low-income subsidy — LIS beneficiaries pay it in full.
Verified Oct 18, 2026 · cms.gov
- Rank 2
LillyDirect self-pay
until Dec 31, 2026$449/moRises to $699/month if the refill condition is missed.
- Refill within 45 days to keep this price
- If the card's savings were not applied at the point of sale, you can claim the difference back in Lilly's patient portal or by post; claims close March 31, 2027
- Lilly's direct channel. Vial and KwikPen at identical self-pay prices at every tier. Telehealth not included.
Verified Oct 22, 2026 · zepbound.lilly.com
- Rank 3
Discount card at retail (GoodRx and similar)
verify locally until Dec 31, 2026$449/moRises to $699/month if the refill condition is missed.
- Refill within 45 days of your previous KwikPen delivery to keep this price; the card's regular price applies otherwise
- Dose- and pharmacy-dependent. Verify at your ZIP before relying on it.
Verified Oct 21, 2026 · goodrx.com
TrumpRx
reference verify locally$299/mo- Routes you to LillyDirect, where the price varies by dose
- Government referral site — does not sell drugs or process payments; issues coupons or routes to manufacturer DTC channels. Every figure it shows is a starting-at price — the site's own column is headed 'Lowest' — so it is a floor for the cheapest dose or intro offer, never a flat price.
Verified Oct 14, 2026 · trumprx.gov
Retail list price (reference)
reference verify locally$1,087/mo- Cited to TrumpRx, which displays $1,087 as Zepbound's list price; drugs.com stopped publishing it and now shows the LillyDirect self-pay tiers instead
- Context anchor only — what the drug costs with no route at all. Walk-in cash at retail typically exceeds WAC.
Verified Oct 14, 2026 · trumprx.gov
Share or post this breakdown
Markdown Summary